Indaptus Therapeutics Inc Share Price

NASDAQ: INDP

Small Cap

$2.60

+0.23

(+9.68%)

as on September 19, 2025 at 1:29 am IST

$₹

Indaptus Therapeutics Inc Stock Performance

as on September 19, 2025 at 1:29 am IST

Day's Low
Day's High
$2.31
Day's Price Range
$2.61
$2.6
11.15%
Downside
0.38%
Upside
52 Week's Low
52 Week's High
$2.22
52-Week Price Range
$58.24
$2.6
14.62%
Downside
2140.00%
Upside

Indaptus Therapeutics Inc share price movements today

Previous Close: $2.37
Open: $2.37
Volume: 410.0K
Day's Low - High: $2.31 - $2.61
52 Week Low - High: $2.22 - $58.24

Indaptus Therapeutics Inc Historical Returns

1 Month Return: -69.45 %
3 Month Return: -74.27 %
1 Year Return: -94 %
3 Year Return: -96.92 %
5 Year Return: -89.51 %

Indaptus Therapeutics Inc Stock Fundamentals & Key Indicators

Check Indaptus Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7M

EPS (TTM)

-26.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-16.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

52912800.00%

Indaptus Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indaptus Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Indaptus Therapeutics Inc	BUY	$2.7M	-89.51%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Indaptus Therapeutics Inc Stock including INR - Dollar returns

The Indaptus Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y
7Y
10Y

Indaptus Therapeutics Inc investment value today

Current value as on today

₹11,539

Returns

₹88,461

(-88.46%)

Returns from Indaptus Therapeutics Inc Stock

₹93,414 (-93.41%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Indaptus Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Indaptus Therapeutics Inc. Average target price of $25

Indaptus Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Indaptus Therapeutics Inc.

What analysts predicted

89.6%UPSIDE

Target Price

$25

Current Price

$2.6

Analyzed by

8 Analysts

Target

$25.00

Indaptus Therapeutics Inc target price $25, a slight upside of 89.6% compared to current price of $2.6. According to 8 analysts rating.

Indaptus Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Indaptus Therapeutics Inc Stock has increased by 78% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 20, 2025 to September 19, 2025

Change:78% versus previous 30 day period

Indaptus Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	-	-	0	-	-
Operating Income	-4	-3	-4	-4	-3	-4	-3	-4	-4	-4
EBITDA	-4	-3	-4	-4	-3	-4	-3	-4	-4	-5
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	-	-	-	-	-
Income Before Tax	-4	-3	-3	-4	-3	-4	-3	-4	-4	-5
Income Tax Expense	0	0	0	-4	0	-	-	0	-	-
Net Income	-4	-3	-3	-4	-3	-4	-3	-4	-4	-5
Net Profit Margin	0.00%	0.00%	0.00%	-207613.07%	0.00%	0.00%	0.00%	-281023.61%	0.00%	0.00%

Indaptus Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	0
Operating Income	-3	-7	-14	-16	-15
EBITDA	-3	-7	-14	-16	-15
Interest Expense	0	0	0	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-3	-7	-14	-15	-15
Income Tax Expense	0	0	0	-16	-
Net Income	-3	-7	-14	-15	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Indaptus Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-3	-4	-3	-4	-3	-4	-4	-5
Operating Cash Flow	-2	-3	-2	-3	-2	-2	-3	-5	-4
Investing Cash Flow	8	7	0	-	-	-	-	-	-
Financing Cash Flow	-	-	-	0	0	2	1	3	6
Change in Cash	5	3	-2	-3	-2	0	-1	-1	2

Indaptus Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-13	-28	-43	-47	-3	-7	-14	-15	-15
Operating Cash Flow	-12	-22	-39	-29	-3	-11	-13	-13	-12
Investing Cash Flow	4	-4	-9	-3	0	0	-16	17	-
Financing Cash Flow	-	63	35	2	1	48	0	-	4
Change in Cash	-7	36	-14	-29	-2	37	-29	3	-7

Global Institutional Holdings in Indaptus Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	0.82%
Investment House LLC	0.41%
Geode Capital Management, LLC	0.4%
Renaissance Technologies Corp	0.09%
Vivaldi Capital Management, LLC	0.08%

See all

Insights on Indaptus Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 162.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 208.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, INDP stock has moved down by -16.3%

About Indaptus Therapeutics Inc

the indaptus goal is simple: to cure disease with the ability to harness both the body’s innate and adaptive immune responses, we believe we are uniquely positioned to revolutionize the treatment of cancer and certain infectious diseases. building on the observation that tumor regression can occur in the setting of bacterial infection, we have developed a proprietary platform that exploits bacteria’s natural ability to activate both innate and adaptive cellular immune pathways. leveraging our novel insights into the levels and ratios of activating signals needed to safely elicit a broad immune response, we are creating and advancing a pipeline of proprietary, attenuated and killed non-pathogenic gram-negative bacterial candidates designed to be widely accessible, with broad anti-tumor and anti-viral activity.

Organisation	Indaptus Therapeutics Inc
Headquarters	Three Columbus Circle, New York, NY, United States, 10019
Industry	Healthcare
CEO	Mr. Jeffrey A. Meckler J.D.
E-voting on shares	Click here to vote

Key Management of Indaptus Therapeutics Inc

Name	Title
Mr. Jeffrey A. Meckler J.D.	CEO & Director
Dr. Michael J. Newman Ph.D.	Founder, Chief Scientific Officer & Director
Mr. Walt Addison Linscott Esq.	Chief Operating Officer
Dr. Roger J. Waltzman M.B.A., M.D.	Chief Medical Officer
Mr. Nir Sassi	CFO, Secretary & Treasurer

FAQs

What is Indaptus Therapeutics Inc share price today?

Indaptus Therapeutics Inc share price today is $2.6 as on September 19, 2025 at 1:29 am IST at the close of the market. Indaptus Therapeutics Inc share today touched a day high of $2.61 and a low of $2.31.

What is the 52 week high and 52 week low for Indaptus Therapeutics Inc share?

Indaptus Therapeutics Inc share touched a 52 week high of $58.24 on October 22, 2024 and a 52 week low of $2.22 on September 15, 2025. Indaptus Therapeutics Inc stock price today i.e. September 19, 2025 at 1:29 am IST is closed at $2.6,which is 95.54% down from its 52 week high and 17.12% up from its 52 week low.

What is Indaptus Therapeutics Inc's market capitalisation today?

Indaptus Therapeutics Inc market capitalisation is $0.00T as on September 19, 2025 at 1:29 am IST.

How to invest in Indaptus Therapeutics Inc Stock (INDP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Indaptus Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indaptus Therapeutics Inc Shares that will get you 0.5769 shares as per Indaptus Therapeutics Inc share price of $2.6 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Indaptus Therapeutics Inc Stock (INDP) from India?

Indian investors can start investing in Indaptus Therapeutics Inc (INDP) shares with as little as ₹88.114 or $1 (as of September 19, 2025 at 3:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Indaptus Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 19, 2025 at 3:41 am IST). Based on Indaptus Therapeutics Inc share’s latest price of $2.6 as on September 19, 2025 at 1:29 am IST, you will get 3.8462 shares of Indaptus Therapeutics Inc. Learn more about fractional shares .

What are the returns that Indaptus Therapeutics Inc has given to Indian investors in the last 5 years?

Indaptus Therapeutics Inc stock has given -89.51% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?